IMA vs K · rev $9.2M vs P/E 23, $29.03B cap
ImageneBio, Inc. (IMA) versus Kellanova (K) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Kellanova (K) is a packaged foods company listed on US.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
K does not have a complete income-statement cache yet.
IMA currently screens at market cap $64.7M. K currently screens at market cap $29.03B and trailing P/E 22.8.
Not investment advice. Open the IMA and K stock pages for the full models.
Not investment advice.